A nurse is assessing a client who is experiencing a change in vision. Which of the following statements indicates that the client might be developing cataracts?
"My vision is blurry and objects are hazy."
"l can't see anything in the middle part of my eyes."
"There are dark spots moving around in my eye."
"l can't see objects from the sides of my eyes."
The Correct Answer is B
A. Severe myopia: Severe myopia refers to nearsightedness and is not typically associated with Meniere's disease. Myopia affects vision but is unrelated to the characteristic symptoms of Meniere's disease.
B. Vertigo: Vertigo is a hallmark symptom of Meniere's disease. It is characterized by a sensation of spinning or dizziness, often accompanied by nausea, vomiting, and imbalance. Vertigo episodes in Meniere's disease can be severe and debilitating, significantly impacting the individual's quality of life.
C. Anosmia: Anosmia refers to a loss of sense of smell and is not a typical manifestation of Meniere's disease. Meniere's disease primarily affects the inner ear and is characterized by symptoms related to vestibular dysfunction, such as vertigo, rather than olfactory disturbances.
D. Photopsia: Photopsia refers to the perception of flashing lights or visual disturbances and is not a characteristic manifestation of Meniere's disease. Visual disturbances may occur in certain conditions affecting the eyes or visual pathways but are not typically associated with Meniere's disease, which primarily affects the inner ear and vestibular system.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","C"]
Explanation
A. Colchicine:
Colchicine is commonly used in the treatment of pericarditis, especially in cases of recurrent or refractory pericarditis.
It helps reduce inflammation and alleviate symptoms by inhibiting the migration of neutrophils to the inflamed pericardium.
Colchicine is often used in conjunction with nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids for the management of pericarditis.
B. Acetaminophen:
Acetaminophen is a pain reliever and fever reducer commonly used to manage mild to moderate pain associated with various conditions, including pericarditis.
While acetaminophen may provide symptomatic relief, it is not typically considered a primary treatment for pericarditis, especially in cases of severe or recurrent pericarditis.
C. Indomethacin:
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that can help reduce inflammation and relieve pain associated with pericarditis.
NSAIDs are often used as first-line therapy for acute pericarditis to alleviate symptoms such as chest pain and fever.
However, caution should be exercised when using NSAIDs in certain populations, such as older adults or those with preexisting gastrointestinal or renal conditions.
D. Amiodarone:
Amiodarone is an antiarrhythmic medication used to treat various types of arrhythmias, including ventricular arrhythmias and atrial fibrillation.
While pericarditis may lead to certain arrhythmias, such as atrial fibrillation, amiodarone is not a first-line treatment for pericarditis itself.
However, it may be used in cases where pericarditis is complicated by arrhythmias or concomitant cardiac conditions.
E. Nitroglycerine:
Nitroglycerine is a vasodilator medication commonly used to treat angina and heart failure.
While pericarditis may cause chest pain similar to angina, nitroglycerine is not typically used as a primary treatment for pericarditis.
In fact, nitroglycerine may exacerbate symptoms of pericarditis by causing venodilation and increasing cardiac preload.
Correct Answer is B
Explanation
A. "Your heart condition is caused by excessive stretching of the ventricles": This statement is incorrect. Excessive stretching of the ventricles typically occurs in dilated cardiomyopathy, not restrictive cardiomyopathy (RCM). In RCM, the primary issue is not excessive stretching but rather stiffening of the ventricular walls.
B. "Your heart condition is caused from stiffening of the walls of the ventricles": This statement is correct. Restrictive cardiomyopathy (RCM) is characterized by abnormal stiffening (fibrosis) of the ventricular walls, which impairs the heart's ability to fill properly during the diastolic phase of the cardiac cycle. This stiffening restricts the heart's ability to relax and fill with blood efficiently.
C. "Your heart condition is caused by thickening of the ventricular walls and septum": This statement describes hypertrophic cardiomyopathy (HCM), not restrictive cardiomyopathy (RCM). In HCM, there is abnormal thickening of the ventricular walls and septum, leading to impaired filling of the ventricles and potential obstruction of blood flow out of the heart.
D. "Your heart condition is caused when the ventricular tissue becomes fibrous and fatty": This statement describes arrhythmogenic right ventricular cardiomyopathy (ARVC), not restrictive cardiomyopathy (RCM). ARVC is characterized by replacement of myocardial tissue with fibrous and fatty tissue, primarily affecting the right ventricle.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.